Skip to main navigation Skip to search Skip to main content

A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

  • Pooja Middha (Contributor)
  • Xiaoliang Wang (Contributor)
  • Sabine Behrens (Contributor)
  • Manjeet K. Bolla (Contributor)
  • Qin Wang (Contributor)
  • Joe Dennis (Contributor)
  • Kyriaki Michailidou (Contributor)
  • Thomas U Ahearn (Contributor)
  • Irene L. Andrulis (Contributor)
  • Hoda Anton-Culver (Contributor)
  • Volker Arndt (Contributor)
  • Kristan J. Aronson (Contributor)
  • Paul L. Auer (Contributor)
  • Annelie Augustinsson (Contributor)
  • Thaïs Baert (Contributor)
  • Laura E. Beane Freeman (Contributor)
  • Heiko Becher (Contributor)
  • Matthias W. Beckmann (Contributor)
  • Javier Sanchez-Benitez (Contributor)
  • Stig E. Bojesen (Contributor)
  • Hiltrud Brauch (Contributor)
  • Hermann Brenner (Contributor)
  • Angela Brooks-Wilson (Contributor)
  • Daniele Campa (Contributor)
  • Federico Canzian (Contributor)
  • Angel Carracedo (Contributor)
  • Jose E. Castelao (Contributor)
  • Stephen J. Chanock (Contributor)
  • Georgia Chenevix-Trench (Contributor)
  • Emilie Cordina-Duverger (Contributor)
  • Fergus J. Couch (Contributor)
  • Angela Cox (Contributor)
  • Simon S. Cross (Contributor)
  • Kamila Czene (Contributor)
  • Laure Dossus (Contributor)
  • Pierre Antoine Dugué (Contributor)
  • A. Heather Eliassen (Contributor)
  • Mikael Eriksson (Contributor)
  • D. Gareth Evans (Contributor)
  • Peter A. Fasching (Contributor)
  • Jonine D. Figueroa (Contributor)
  • Olivia Fletcher (Contributor)
  • Henrik Flyger (Contributor)
  • Marike Gabrielson (Contributor)
  • Manuela Gago-Dominguez (Contributor)
  • Graham G. Giles (Contributor)
  • Anna González-Neira (Contributor)
  • Felix Grassmann (Contributor)
  • Anne Grundy (Contributor)
  • Pascal Guénel (Contributor)
  • Christopher A. Haiman (Contributor)
  • Niclas Håkansson (Contributor)
  • Per F.L. Hall (Contributor)
  • Ute Hamann (Contributor)
  • Susan E. Hankinson (Contributor)
  • Elaine F. Harkness (Contributor)
  • Bernd Holleczek (Contributor)
  • Reiner Hoppe (Contributor)
  • John L. Hopper (Contributor)
  • Richard S. Houlston (Contributor)
  • Anthony Howell (Contributor)
  • David J Hunter (Contributor)
  • Christian Ingvar (Contributor)
  • Karolin Isaksson (Contributor)
  • Helena Jernström (Contributor)
  • Esther M. John (Contributor)
  • Michael E. Jones (Institute of Cancer Research) (Contributor)
  • Rudolf Kaaks (Contributor)
  • Renske Keeman (Contributor)
  • Cari M. Kitahara (Contributor)
  • Yon Dschun Ko (Contributor)
  • Stella Koutros (Contributor)
  • Allison W. Kurian (Contributor)
  • James V. Lacey (Contributor)
  • Diether Lambrechts (Contributor)
  • Nicole L. Larson (Contributor)
  • Susanna C. Larsson (Contributor)
  • Loic Le Marchand (Contributor)
  • Flavio Lejbkowicz (Contributor)
  • Shuai Li (Monash University, University of Melbourne, University of Cambridge) (Contributor)
  • Martha Linet (Contributor)
  • Jolanta Lissowska (Contributor)
  • Maria Elena Martinez (University of California (San Diego) (Contributor)
  • Tabea Maurer (Contributor)
  • Anna Marie Mulligan (Contributor)
  • Claire Mulot (Contributor)
  • Rachel A. Murphy (University of British Columbia) (Contributor)
  • William G. Newman (Contributor)
  • Sune F. Nielsen (Herlev and Gentofte Hospital) (Contributor)
  • Børge G. Nordestgaard (Contributor)
  • Aaron Norman (Contributor)
  • Katie M. O'Brien (Contributor)
  • Janet E. Olson (Contributor)
  • Alpa V. Patel (Contributor)
  • Ross Prentice (Contributor)
  • Erika Rees-Punia (Contributor)
  • Gad Rennert (Contributor)
  • Valerie Rhenius (Contributor)
  • Kathryn J. Ruddy (Contributor)
  • Dale P. Sandler (Contributor)
  • Christopher G. Scott (Mayo Clinic) (Contributor)
  • Mitul Shah (Contributor)
  • Xiao Ou Shu (Contributor)
  • Ann Smeets (Contributor)
  • Melissa C. Southey (Contributor)
  • Jennifer Stone (Contributor)
  • Rulla M. Tamimi (Contributor)
  • Jack A. Taylor (National Institute of Environmental Health Sciences) (Contributor)
  • Lauren R. Teras (Contributor)
  • Katarzyna Tomczyk (Contributor)
  • Melissa A. Troester (Contributor)
  • Thérèse Truong (Contributor)
  • Celine M. Vachon (Contributor)
  • Sophia S. Wang (Contributor)
  • Clarice R. Weinberg (Contributor)
  • Hans Wildiers (Contributor)
  • Walter C. Willett (Contributor)
  • Stacey J. Winham (Contributor)
  • Alicja Wolk (Contributor)
  • Xiaohong R. Yang (Contributor)
  • Pilar M. Zamora (Contributor)
  • Wei Zheng (Contributor)
  • Argyrios Ziogas (Contributor)
  • Alison M. Dunning (Contributor)
  • Paul D.P. Pharoah (Contributor)
  • Montserrat García-Closas (Contributor)
  • Marjanka K. Schmidt (Contributor)
  • Peter Kraft (Contributor)
  • Roger L. Milne (Contributor)
  • Sara Lindström (Contributor)
  • Douglas F. Easton (Contributor)
  • Jenny Chang-Claude (Contributor)

Dataset

Description

Abstract Background Genome-wide studies of gene–environment interactions (G×E) may identify variants associated with disease risk in conjunction with lifestyle/environmental exposures. We conducted a genome-wide G×E analysis of ~ 7.6 million common variants and seven lifestyle/environmental risk factors for breast cancer risk overall and for estrogen receptor positive (ER +) breast cancer. Methods Analyses were conducted using 72,285 breast cancer cases and 80,354 controls of European ancestry from the Breast Cancer Association Consortium. Gene–environment interactions were evaluated using standard unconditional logistic regression models and likelihood ratio tests for breast cancer risk overall and for ER + breast cancer. Bayesian False Discovery Probability was employed to assess the noteworthiness of each SNP-risk factor pairs. Results Assuming a 1 × 10–5 prior probability of a true association for each SNP-risk factor pairs and a Bayesian False Discovery Probability < 15%, we identified two independent SNP-risk factor pairs: rs80018847(9p13)-LINGO2 and adult height in association with overall breast cancer risk (ORint = 0.94, 95% CI 0.92–0.96), and rs4770552(13q12)-SPATA13 and age at menarche for ER + breast cancer risk (ORint = 0.91, 95% CI 0.88–0.94). Conclusions Overall, the contribution of G×E interactions to the heritability of breast cancer is very small. At the population level, multiplicative G×E interactions do not make an important contribution to risk prediction in breast cancer.
Date made available14 Aug 2024
PublisherFigshare

Cite this